Innovation and Experience
Building on an unparalleled breadth of technology and the expertise gained in nearly forty years of automating laboratory processes, STRATEC has established itself as one of the world’s leading providers of automation solutions for in-vitro diagnostics and life science companies.
We have consistently extended our business model and aligned it ever more closely to the needs of our partners. That is why in addition to pure instrumentation we now cover virtually the entire value chain for the specification, design, manufacture and approval of complex analyzer system solutions – developing and integrating complex consumables, instrumentation and complementary middleware laboratory software.
We have always been an early mover when it comes to seizing new technologies and applications and integrating these into our existing technology portfolio, whether by way of proprietary development work or in partnership with our customers.
As the innovative and technological market leader for automation and instrumentation solutions in in vitro diagnostics, we seek to offer our worldwide partners first class solutions and thereby share responsibility toward their customers and patients.
Our success is based on the talents and skills of our employees and their commitment to always perform the extraordinary. Their performance allows for the successful and sustainable development of our company in the interest of all its stakeholders.
Our partnerships are built on mutual trust, continuity and professionalism and with our partners we share a common mission to develop safe, innovative, market-leading products that consistently fulfill customer expectations. For STRATEC, partnership means responsibility, passion and commitment, to both our customers and our products, that goes well beyond the duration of the product life cycle.
Since its inception, STRATEC has embraced a personal responsibility towards its people, the community and the environment. This philosophy continues to guide the day-to-day work of employees and STRATEC maintains close links to local and regional communities and their administrative structures. Sustainable and responsible entrepreneurial action remain a key priority at our company.
In 2014, STRATEC published its first CSR Report detailing its organizational goals and sustainable activities:
- Nachhaltigkeitsbericht 2014 (only available in German)
- Nachhaltigkeitsbericht 2015 (deutsch)
- CSR Report 2015 2015 (english)
- Nachhaltigkeitsbericht 2016 (deutsch)
- CSR-Report 2016 (english)
STRATEC is a major employer for many citizens in the area around its Birkenfeld headquarters and other areas in which the divisions operate. STRATEC has worked very closely with regional suppliers and local tradesmen to demonstrate its commitment and become an integral part of these communities. These efforts are viewed as core components of sustainable business success. This creates a sense of personal responsibility towards our people and our environment, one that is the basis of our day-to-day work. Structures evolve as a result, and these are then lived and mapped onto other locations.
For inquiries regarding STRATEC’s Corporate Sustainability Policy, please contact email@example.com
STRATEC Succeeds When its Partners Succeed
The STRATEC Group is committed to continually enhancing its processes and service quality. One of STRATEC’s fundamental obligations is to structure its business processes so that it and its partners – diagnostics and life science companies operating in highly regulated worldwide markets – meet regulatory and legal requirements in a continually changing environment. STRATEC’s commitment to satisfy regulatory standards enhances its partners’ positions in their respective markets.
STRATEC’s success is derived from the economic viability of its partners. Clearly defined processes throughout the value chain, from the initial development steps through to serial production, play a crucial role in safeguarding permanent market success. At the same time, a flexible quality management system also facilitates compliance with the necessary international requirements enabling STRATEC to work together with its OEM partners to access new markets rapidly and efficiently.
STRATEC’s complaint handling system supports the service and vigilance process – as well as its partners’ risk management – by offering interdisciplinary error analyses and risk assessments. Additionally, STRATEC actively involves its partners in relevant control steps within the change process.
Your Experts in Hematology and Clinical Chemistry
The Diatron business unit develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for human medical and veterinary use. Diatron’s expertise enables STRATEC to develop and produce smaller-scale systems and modules, thus rounding out its portfolio.
Board of Management
Dr. Robert Siegle
Dr. Claus Vielsack
Fred K. Brückner
Prof. Dr. Stefanie Remmele
Stratec is founded in Birkenfeld, Germany
First medical systems are developed
Systems for bio- and chemi-luminescence and coagulation applications are launched
Development work on an automation platform for microplate applications commences
STRATEC Biomedical Inc. is founded in the US
Publicity traded company
STRATEC becomes a publicity traded company
STRATEC NewGen GmbH
STRATEC NewGen GmbH is founded in Birkenfeld, Germany
Robion AG is founded in Switzerland
Sanguin International Ltd.
Acquisition of Sanguin International Ltd. (UK) and its US subsidiary
STRATEC Biomedical Systems S.R.L. is founded in Romania
Acquisition of Invitek Gesellschaft für Biotechnik & Biodesign mbH in Berlin, Germany
Acquisition of Ballista Inc. in Newbury Park, California, USA
STRATEC Biomedical (Taicang) is founded in China
Acquisition of Diatron MI PLC, Budapest, Hungary
STRATEC Consumables (Sony DADC BioSciences)
Acquisition of Sony DADC BioSciences, now STRATEC Consumables